-
-
MyCelx reports $20-22M pipeline with contract awards expected
-
Why is Lucid stock rallying today?
-
Europe has a new way to annoy Trump: A ‘hostile’ trade pact with Canada as an ‘associate member’ of the EU
Good morning. On Fortune’s radar today: Salesforce’s Marc Benioff warns AI industry: Regulate or prepare to be sued. Trump hates ‘hostile’ Canada-Europe alliance. What if AI is a commodity product that competes mostly on price? Labor’s share of national income in historic decline. Markets: Mixed, but U.S. futures are up. Everyone is moving their gold…
-
When it comes to rate hikes, CFOs aren’t counting on a ‘one-and-done’
Good morning. The Federal Open Market Committee voted unanimously on Wednesday to raise its benchmark rate a quarter point, to 3.75%-4%, the first hike since July 2023 and the first policy move of Chairman Kevin Warsh’s tenure. The decision put Warsh at odds with President Trump, who has publicly pushed for a rate cut .…
-
Mets’ David Stearns Makes Striking Move As Fans Cheer Orioles’ Pete Alonso
The New York Mets executive was the focus of a two-word demand from fans as former slugger Pete Alonso returned.
-
Whiskey Tariffs Impact The Market For Brown Liquor
A new study of Trump’s 2018 whiskey tariffs shows how retaliation reshaped U.S. prices, as Irish and UK whiskey tariffs get lifted in 2026.
-
Almonty rises after signing tungsten offtake deal with Sandvik
-
Braves Offer 4-Word Response On 2-Time All-Star’s Surprising Injury Update
Atlanta Braves manager Walt Weiss “wasn’t expecting” the latest injury update on the team’s new $45 million star.
-
CVS’ Aetna To Meld Cancer Treatment Approvals As Insurers Cut Hurdles
CVS Health’s Aetna will bundle cancer treatments into a single clinical review as the industry works to further eliminate the controversial prior authorization process.